Oakley C. Olson

ORCID: 0000-0002-0716-5380
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immune cells in cancer
  • Cancer Immunotherapy and Biomarkers
  • Acute Myeloid Leukemia Research
  • Protease and Inhibitor Mechanisms
  • Peptidase Inhibition and Analysis
  • Hematopoietic Stem Cell Transplantation
  • Anorectal Disease Treatments and Outcomes
  • S100 Proteins and Annexins
  • Cell Adhesion Molecules Research
  • Immune Response and Inflammation
  • Bacterial Infections and Vaccines
  • Reproductive tract infections research
  • Immunotherapy and Immune Responses
  • Glioma Diagnosis and Treatment
  • Diabetes Management and Research
  • Monoclonal and Polyclonal Antibodies Research
  • Histone Deacetylase Inhibitors Research
  • Hepatitis C virus research
  • Connective tissue disorders research
  • Infant Nutrition and Health
  • Reproductive System and Pregnancy
  • Spondyloarthritis Studies and Treatments
  • Cancer Risks and Factors
  • Cancer, Hypoxia, and Metabolism
  • Hepatitis B Virus Studies

Columbia University
2020-2024

Mayo Clinic
2024

Broad Center
2021

University of California, San Francisco
2021

New York Stem Cell Foundation
2020

Memorial Sloan Kettering Cancer Center
2012-2017

University of Lausanne
2017

Ludwig Cancer Research
2017

Cancer Genetics (United States)
2011

Stanford University
2008

The microenvironment is known to critically modulate tumor progression, yet its role in regulating treatment response poorly understood. Here we found increased macrophage infiltration and cathepsin protease levels mammary tumors following paclitaxel (Taxol) chemotherapy. Cathepsin-expressing macrophages protected against Taxol-induced cell death coculture, an effect fully reversed by inhibition mediated partially cathepsins B S. Macrophages were also protect induced additional...

10.1101/gad.180331.111 article EN Genes & Development 2011-12-01

Abstract Tumor relapse after chemotherapy-induced regression is a major clinical problem, because it often involves inoperable metastatic disease. Tumor-associated macrophages (TAM) are known to limit the cytotoxic effects of chemotherapy in preclinical models cancer. Here, we report that an alternatively activated (M2) subpopulation TAMs (MRC1+TIE2HiCXCR4Hi) accumulate around blood vessels tumors chemotherapy, where they promote tumor revascularization and relapse, part, via VEGF-A release....

10.1158/0008-5472.can-14-3587 article EN Cancer Research 2015-08-13

Antimitotic agents, including Taxol, disrupt microtubule dynamics and cause a protracted mitotic arrest subsequent cell death. Despite the broad utility of these drugs in breast cancer other tumor types, clinical response remains variable. Tumor-associated macrophages (TAMs) suppress duration Taxol-induced cells promote earlier slippage. This correlates with decrease phosphorylated form histone H2AX (γH2AX), decreased p53 activation, reduced death interphase. TAMs viability following...

10.1016/j.celrep.2017.03.038 article EN cc-by-nc-nd Cell Reports 2017-04-01

Abstract Perineural invasion (PNI) is an ominous event strongly linked to poor clinical outcome. Cells residing within peripheral nerves collaborate with cancer cells enable PNI, but the contributing conditions tumor microenvironment are not well understood. Here, we show that CCR2-expressing inflammatory monocytes (IM) preferentially recruited sites of where they differentiate into macrophages and potentiate nerve through a cathepsin B–mediated process. A series adoptive transfer...

10.1158/0008-5472.can-17-1612 article EN Cancer Research 2017-09-27

Obesity-associated inflammation promotes tumor growth and metastatic spread

10.1126/science.aao5801 article EN Science 2017-11-30

Development of a successful hepatitis C virus (HCV) vaccine requires the definition neutralization epitopes that are conserved among different HCV genotypes. Five human monoclonal antibodies (HMAbs) described cross-compete with other to cluster overlapping epitopes, previously designated domain B. Each HMAb broadly neutralizes retroviral pseudotype particles expressing E1 and E2 glycoproteins, as well infectious chimeric genotype 1a 2a viruses. Alanine substitutions residues within region...

10.1128/jvi.02475-07 article EN Journal of Virology 2008-04-10

Deregulated cathepsin proteolysis occurs across numerous cancers, but in vivo substrates mediating tumorigenesis remain ill-defined. Applying 8-plex iTRAQ terminal amine isotopic labeling of (TAILS), a systems-level N-terminome degradomics approach, we identified B, H, L, S, and Z cleavage sites with the use six different knockout genotypes Rip1-Tag2 mouse model pancreatic neuroendocrine tumorigenesis. Among 1,935 proteins 1,114 N termini by TAILS, stable proteolytic products were wild-type...

10.1016/j.celrep.2016.06.086 article EN cc-by-nc-nd Cell Reports 2016-07-29

Hematopoietic stem cells (HSC) and downstream lineage-biased multipotent progenitors (MPP) tailor blood production control myelopoiesis on demand. Recent lineage tracing analyses revealed MPPs to be major functional contributors steady-state hematopoiesis. However, we still lack a precise resolution of myeloid differentiation trajectories cellular heterogeneity in the MPP compartment. Here, found that myeloid-biased MPP3 are functionally molecularly heterogeneous, with distinct subset...

10.1084/jem.20230088 article EN cc-by The Journal of Experimental Medicine 2023-04-26

ABSTRACT A challenge in hepatitis C virus (HCV) vaccine development is defining conserved protective epitopes. cluster of these epitopes comprises an immunodominant domain on the E2 glycoprotein, designated B. CBH-2 a neutralizing human monoclonal antibody to B epitope that highly conserved. Alanine scanning demonstrated involves residues G523, G530, and D535 are also contact for binding CD81, coreceptor required entry into cells. However, another residue, located at position 431 thus...

10.1128/jvi.00252-08 article EN cc-by Journal of Virology 2008-04-03

Until a uniform classification system is adopted, it will be hard to compare studies of football injuries. This author believes that the picture not as grim often reported.

10.1080/00913847.1979.11710899 article EN The Physician and Sportsmedicine 1979-12-01

An oncogenic splice variant of the transcription factor KLF6 is associated with metastasis and poor survival in node-negative breast cancer patients promotes epithelial-to-mesenchymal transition by regulating Twist.

10.1126/scitranslmed.3005424 article EN Science Translational Medicine 2013-01-23
Coming Soon ...